A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain

Addictive Behaviors

Volumn 33, Issue 1, 2008, Pages 173-179

  Toll, Benjamin A ^a   Leary, Vanessa ^a   Wu, Ran ^a   Salovey, Peter ^b   Meandzija, Boris ^a   O'Malley, Stephanie S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Bupropion; Naltrexone; Smoking cessation; Weight

Indexed keywords

AMFEBUTAMONE; DEPADE; NALTREXONE; NICOTINE; UNCLASSIFIED DRUG;

ABSTINENCE; ADULT; ALOPECIA; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DIZZINESS; DRUG DOSE REGIMEN; FATIGUE; FEMALE; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; LOW DRUG DOSE; MALE; NAUSEA; NERVOUSNESS; OPEN STUDY; OUTCOMES RESEARCH; PREVALENCE; PRURITUS; RELAPSE; SIDE EFFECT; SMOKING CESSATION; SWEATING; TINNITUS; TOBACCO DEPENDENCE; VOMITING; WEIGHT GAIN; XEROSTOMIA;

ADULT; BUPROPION; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; DOPAMINE UPTAKE INHIBITORS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; SMOKING CESSATION; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 35748943520     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2007.05.012     Document Type: Article

References (15)

1. Brown R.A., Burgess S.A., Sales S.D., Whiteley J.A., Evans D.M., and Miller I.W. Reliability and validity of a smoking Timeline Followback interview. Psychology of Addictive Behaviors 12 (1998) 101-112
2. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. (1988), Lawrence Earlbaum Associates, Hillsdale, NJ
3. Covey L.S., Glassman A.H., and Stetner F. Naltrexone effects on short-term and long-term smoking cessation. Journal of Addictive Diseases 18 (1999) 31-40
4. Dale L.C., Glover E.D., Sachs D.P., Schroeder D.R., Offord K.P., Croghan I.T., et al. Bupropion for smoking cessation: Predictors of successful outcome. Chest 119 (2001) 1357-1364
5. Fiore M.C., Bailey W.C., Cohen S.J., Dorfman S.F., Goldstein M.G., Gritz E.R., et al. Treating tobacco use and dependence: Clinical practice guideline (2000), U.S. DHHS, Rockville, MD
6. Gonzalez D., Rennard S.I., Nides M., Oncken C., Azoulay S., Billing C.B., et al. Varenicline, an alpha-4-beta-2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. The Journal of the American Medical Association 296 (2006) 47-55
7. Hurt R.D., Sachs D.P., Glover E.D., Offord K.P., Johnston J.A., Dale L.C., et al. A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine 337 (1997) 1195-1202
8. King A., de Wit H., Riley R.C., Cao D., Niaura R., and Hatsukami D. Efficacy of naltrexone in smoking cessation: A preliminary study and an examination of sex differences. Nicotine & Tobacco Research 8 (2006) 671-682
9. Krishnan-Sarin S., Meandzija B., and O'Malley S.S. Naltrexone and nicotine patch in smoking cessation: A preliminary study. Nicotine & Tobacco Research 5 (2003) 851-857
10. O'Malley S.S., Cooney J.L., Krishnan-Sarin S., Dubin J.A., McKee S.A., Cooney N.L., et al. Controlled trial of naltrexone augmentation of nicotine replacement for smoking cessation. Archives of Internal Medicine 166 (2006) 667-674
11. Perkins K.A., Marcus M.D., Levine M.D., D'Amico D., Miller A., Broge M., et al. Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weight-concerned women. Journal of Consulting and Clinical Psychology 69 (2001) 604-613
12. Pomerleau C.S., Zucker A.N., and Stewart A.J. Characterizing concerns about post-cessation weight gain: Results from a national survey of women smokers. Nicotine & Tobacco Research 3 (2001) 51-60
13. Swan G.E., Jack L.M., Curry S., Chorost M., Javitz H., McAfee T., et al. Bupropion SR and counseling for smoking cessation in actual practice: Predictors of outcome. Nicotine & Tobacco Research 5 (2003) 911-921
14. Toll, B.A., O'Malley, S.S., Katulak, N.A., Wu, R., Dubin, J., Latimer, A., et al. (in press). Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: A randomized controlled trial. Psychology of Addictive Behaviors.
15. Wong G.Y., Wolter T.D., Croghan G.A., Croghan I.T., Offord K.P., and Hurt R.D. A randomized trial of naltrexone for smoking cessation. Addiction 94 (1999) 1227-1237